Embecta's compelling ~44% free cash flow yield offers a strong risk-reward despite headwinds from new insulin technologies ...

Chief Executive Officer of embecta. "We remain on track to complete the restructuring plan associated with the discontinuation of the insulin patch pump progr PARSIPPANY, N.J., Feb. 06 ...

Embecta CEO. “We remain on track to complete the restructuring plan associated with the discontinuation of the insulin patch pump program by the end of the first half of the fiscal year and are ...

Embecta Corporation (($EMBC)) has held its Q1 earnings call. Read on for the main highlights of the call. Embecta Corporation’s recent earnings ...

23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp ... to better manage insulin delivery through a patch pump with a larger, 300-unit (u) insulin reservoir, which could provide longer wear times ...

Embecta Corp. (NASDAQ:EMBC) announced that its Annual Meeting of Stockholders, which took place on Monday, resulted in the election of Class III directors and the ratification of the company's ...

Kurdikar outlined plans to leverage Embecta's commercial channel in ... raised questions about residual value from the discontinued insulin patch pump program. Kurdikar stated that while no ...

Chief Executive Officer of embecta. "We remain on track to complete the restructuring plan associated with the discontinuation of the insulin patch pump program by the end of the first half of the ...

(“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, presented two abstracts at the American Diabetes Association’s 84th Scientific Sessions that ...

However, Embecta announced the discontinuation of its insulin patch pump program due to high investment costs and competitive pressures. On the personnel front, Embecta Corp. announced the ...

We recently published a list of These Were Last Week’s 10 Worst Dividend Stocks. In this article, we are going to take a look ...